Volitionrx (VNRX) Other Non-Current Liabilities (2020 - 2026)

Volitionrx's (VNRX) quarterly Other Non-Current Liabilities came in at $112770.0 in Q3 2025, down 19.8% on a QoQ basis from $140612.0 in Q2 2025.

Volitionrx (VNRX) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends

Volitionrx (VNRX) has 5 years of Other Non-Current Liabilities data on file, last reported at $112770.0 in Q3 2025.

Quarterly Other Non-Current Liabilities changed N/A year-over-year to $112770.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $112770.0 (changed N/A YoY) and the FY2023 annual result came in at $126649.0, changed N/A from the prior year.
Other Non-Current Liabilities declined to $112770.0 in Q3 2025, from $140612.0 in the prior quarter.
In the past five years, Other Non-Current Liabilities ranged from a high of $140612.0 in Q2 2025 to a low of $55404.0 in Q2 2021.
A 4-year average of $84936.9 and a median of $66626.0 in 2021 frame the typical range for Other Non-Current Liabilities.
The widest YoY moves for Other Non-Current Liabilities: up 0.0% in 2021, down 0.0% in 2021.
Tracing VNRX's Other Non-Current Liabilities over 4 years: stood at $55404.0 in 2021, then changed by 0.0% to $55404.0 in 2022, then soared by 128.59% to $126649.0 in 2023, then declined by 10.96% to $112770.0 in 2025.
The last three Other Non-Current Liabilities figures came in at $112770.0 (Q3 2025), $140612.0 (Q2 2025), and $77848.0 (Q1 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	Volitionrx	1.19 Mn	-1.60 Mn	-

Download Data